NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors
European Journal of Cancer2019Vol. 108, pp. 78–87
Citations Over TimeTop 1% of 2019 papers
Andrea Wang‐Gillam, Richard Hubner, Jens T. Siveke, Daniel D. Von Hoff, Bruce Belanger, Floris A. de Jong, Beloo Mirakhur, Li‐Tzong Chen
Abstract
NCT01494506.
Related Papers
- → Folinic Acid Does Improve 5-Fluorouracil ActivityIn Vivo.Results of a Phase III Study Comparing 5-Fluorouracil to 5-Fluorouracil and Folinic Acid in Advanced Colon Cancer Patients(1993)22 cited
- → Cost-effectiveness analysis of irinotecan plus fluorouracil/folinic acid compared with fluorouracil/folinic acid alone as first-line treatment for advanced colorectal cancer(2003)2 cited
- [Irinotecan in combination for colon cancer].(1998)
- [Comparison of fluorouracil + folinic acid, fluorouracil + levamisole and fluorouracil + folinic acid + levamisole in Dukes' B and C colon cancer: NSABP Trial C-04].(2000)
- [Fluorouracil and high-dose folinic acid in the treatment of advanced colorectal carcinoma].(1990)